CompanyR&D

Takeda Reinforces Takeda Spark Incubator Program with Expanded Partnerships in China

Company

Novocure Restructures and Prioritizes Pipeline Amid Anticipated NSCLC Approval

CompanyDrug

AbbVie’s Telisotuzumab-Vedotin Shows Promising Results in NSCLC Phase 2 Trial

CompanyDeals

Boehringer Ingelheim Partners with Phenomic AI to Target Stroma-Rich Cancers

CompanyDrug

Jiangsu Hengrui Receives NMPA Approval for Esophageal Cancer and Breast Cancer Clinical Trials

CompanyDrug

Asieris Pharmaceuticals’ Hexvix for Bladder Cancer Accepted for Review by China’s NMPA

CompanyDrug

Jiangxi Jemincare’s KRAS Inhibitor Earns Breakthrough Designation from China’s CDE for NSCLC

CompanyDeals

Eli Lilly Partners with Prism BioLab to Discover Peptide-Mimicking Small Molecule Inhibitors

CompanyDrug

Roche’s Mosunetuzumab and AnHeart’s Taletrectinib Poised for Priority Review in China

Policy / Regulatory

China’s CDE Expands Market Approval Services with Two New Regional Windows

CompanyDrug

Sinocelltech’s PD-1 Inhibitor SCT-I10A for HNSCC Accepted for NMPA Review

CompanyDeals

Bosscome Science & Technology Secures Series A Funding for Precision Medical Navigation Systems